Valitor
Phase 3Valitor is initially focused on improving patient outcomes in ophthalmology and vision-threatening diseases by conquering long-standing limitations of traditional biologic medicines.
Founded
2020
Focus
Biologics
About
Valitor is initially focused on improving patient outcomes in ophthalmology and vision-threatening diseases by conquering long-standing limitations of traditional biologic medicines.
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePhase 3
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile